The Magazine for Sleep Professionals
Wednesday, October 14, 2026
Sommetrics, a private company developing products and services to improve sleep health, released an update on its key accomplishments during the first quarter of 2022. Chief among these accomplishments was the Company’s advancing clinical activities aimed at obtaining FDA market clearance for its flagship product, aerSleep® II, that is targeted […]
Fisher & Paykel Healthcare has announced the United States launch of F&P Evora™ Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment. The mask has received FDA 510(k) clearance, paving the way for its sale into the United States following its launch in Australia, New Zealand, Europe and […]
Fisher & Paykel Healthcare Corporation Limited provided revenue guidance for the financial year ending 31 March 2022. At current exchange rates, the company expects full year operating revenue for the 2022 financial year to be in the range of $1.675 billion to $1.70 billion. Managing Director and Chief Executive Officer […]
A 5-year pioneering collaboration between Cardiology Consultants of Philadelphia (CCP), one of the largest cardiology practices in the country, a number of high-quality local sleep centers, and CleveMed, a leading home sleep testing (HST) technology and fulfillment service provider, was recently endorsed by the American Academy of Sleep Medicine (AASM) […]
LivaNova PLC has announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation” (OSPREY). The randomized controlled trial (RCT) seeks to demonstrate the safety and effectiveness of the LivaNova aura6000™ System, an implantable hypoglossal neurostimulator intended to treat adult patients with […]
By David Schwartz, DDS The June 2021 recall notification of positive airway pressure (PAP) machines by Philips has had a significant impact on sleep centers and their patients. While machine repair and replacement efforts are underway, high demand amid supply shortages requires clinicians to adjust both treatment protocols for […]
The quality of sleep, e.g., sleep stages and arousals from sleep, can be assessed based on the electroencephalogram (EEG) signal recorded during a polysomnogram. Even though arousals from sleep are identified from overnight recordings to characterize the degree of sleep interruption, this information is seldom utilized when assessing OSA severity. […]
Obstructive sleep apnea (OSA) is common among people with primary Sjögren’s syndrome, a study found. Sjögren’s syndrome is a chronic autoimmune disorder that primarily affects the glands producing tears and saliva, leading to symptoms of dryness in the eyes and mouth, but also can affect multiple other tissues. Since OSA is […]
AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnea (OSA) in adults, has obtained FDA 510(k) clearance as a Class II medical device in the USA. The device, developed and commercialized by UK-based medical device company Acurable, builds on more than ten […]
Due to potential health risks, Philips Respironics voluntarily recalled certain continuous positive airway pressure (CPAP) machines over the summer. , the polyester-based polyurethane (PE-PUR) sound abatement foam runs the risk of breaking down and potentially entering the device’s air pathway. Under these circumstances, it is said that black debris from […]
